Skip to main content
VTRSViatris Inc.Sell5.4·$15.94-1.64%
Open full analysis

Viatris Inc. (VTRS) Stock Analysis

Range Bound setup

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Drug Manufacturers - Specialty & Generic

Sell if holding. Engine safety override at $15.94: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: Elevated put/call ratio: 4.09; Below-average business quality.

Viatris is a global pharma company supplying generics, branded, and innovative medicines to ~1 billion patients annually across 165+ countries through four segments (Developed Markets, Emerging Markets, JANZ, Greater China), with 2025 total revenues of $14.30 billion. Following... Read more

QualityF-score8 / 9FCF yield11.86%
IncomeYield2.96%(5y avg 4.08%)Payout960.00%at-risk
Stop $15.20Target $17.05(resistance)A.R:R -0.3:1
Analyst target$18.06+13.3%9 analysts
$17.05our TP
$15.94price
$18.06mean
$12
$23

Sell if holding. Engine safety override at $15.94: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: Elevated put/call ratio: 4.09; Below-average business quality. Chart setup: RSI 41 mid-range, Bollinger mid-band. Score 5.4/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 57d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and 8k serious 2.05. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-10
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202657d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Target reached (-1.4% upside)
Quality below floor (3.4 < 4.0)
Value-trap signals (2/5): Margin compression (op margin 2.8%), Negative free cash flow

Key Metrics

P/E (TTM)
P/E (Fwd)6.1
Mkt Cap$18.9B
EV/EBITDA7.5
Profit Mgn-2.0%
ROE-2.0%
Rev Growth8.1%
Beta0.90
Dividend2.96%
Rating analysts18

Quality Signals

Piotroski F8/9

Options Flow

P/C4.09bearish
IV56%elevated
Max Pain$6-62.4% vs spot

Material Events(8-K, last 90d)

  • 2026-05-04Item 5.02MEDIUM
    CFO Theodora Mistras resigned effective May 8, 2026 to pursue another opportunity. Paul Campbell (current CAO/Controller) appointed interim CFO effective May 8, 2026 while Board searches for permanent CFO. No disagreement cited.
    SEC filing →
  • 2026-02-26Item 2.05MEDIUM
    Viatris announced EWSR restructuring: global workforce reduction of up to ~10%, total pre-tax charges of $700M-$850M expected over ~3 years, targeting $600-700M in savings. Includes headcount cuts, facility closures, and supply chain optimization.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Unprofitable operations — net margin -2.0%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Roa
1.5
Operating Margin
2.7
Gross Margin
4.0
Moat
4.4
Current Ratio
5.8
Piotroski F
8.9
No competitive moatStrong Piotroski F-Score: 8/9
GatesA.R:R -0.3=NEGATIVE8K SERIOUS 2.05Momentum 4.7<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.7>=4.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 57d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Moderate
RSI
41 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $15.50Resistance $17.40

Price Targets

$15
$17
A.Upside+7.0%
A.R:R-0.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-1.4% upside)
! Quality below floor (3.4 < 4.0)
! Value-trap signals (2/5): Margin compression (op margin 2.8%), Negative free cash flow

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-06 (57d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is VTRS stock a buy right now?

Sell if holding. Engine safety override at $15.94: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: Elevated put/call ratio: 4.09; Below-average business quality. Chart setup: RSI 41 mid-range, Bollinger mid-band. Prior stop was $15.20. Score 5.4/10, moderate confidence.

What is the VTRS stock price target?

Take-profit target: $17.05 (+7.0% upside). Prior stop was $15.20. Stop-loss: $15.20.

What are the risks of investing in VTRS?

Target reached (-1.4% upside); Quality below floor (3.4 < 4.0); Value-trap signals (2/5): Margin compression (op margin 2.8%), Negative free cash flow.

Is VTRS overvalued or undervalued?

Viatris Inc. trades at a P/E of N/A (forward 6.1). TrendMatrix value score: 8.1/10. Verdict: Sell.

What do analysts say about VTRS?

18 analysts cover VTRS with a consensus score of 3.8/5. Average price target: $18.

What does Viatris Inc. do?Viatris is a global pharma company supplying generics, branded, and innovative medicines to ~1 billion patients...

Viatris is a global pharma company supplying generics, branded, and innovative medicines to ~1 billion patients annually across 165+ countries through four segments (Developed Markets, Emerging Markets, JANZ, Greater China), with 2025 total revenues of $14.30 billion. Following its 2025 enterprise-wide strategic review, it is executing a restructuring targeting $600-700M in savings and a ~10% global headcount reduction.

Related stocks: INDV (Indivior Pharmaceuticals, Inc.) · NBIX (Neurocrine Biosciences, Inc.) · BHC (Bausch Health Companies Inc.) · SUPN (Supernus Pharmaceuticals, Inc.) · KNSA (Kiniksa Pharmaceuticals Interna)
Home Stocks VTRS

Latest news

Latest News

Benzinga28d agoFda Decision
Benzinga38d ago
Benzinga38d agoAnalyst
Benzinga38d agoAnalyst
Benzinga38d ago
Benzinga39d agoEarnings
Benzinga39d ago
Benzinga42d agoLeadership Change
Benzinga45d agoFda Decision
Benzinga60d agoFda Decision
Benzinga61d agoAnalyst